(Q46769733)

25 December 2017

title

Exposure-response analysis for spontaneously reported dizziness in pregabalin-treated patient with generalized anxiety disorder (English)

1 reference

25 December 2017

1 reference

K Ito

1

1 reference

25 December 2017

Mm Hutmacher

2

1 reference

25 December 2017

J Liu

3

1 reference

25 December 2017

R Qiu

4

1 reference

25 December 2017

B Frame

5

1 reference

25 December 2017

R Miller

6

1 reference

25 December 2017

language of work or name

English

0 references

publication date

6 February 2008

1 reference

25 December 2017

Clinical Pharmacology & Therapeutics

published in

1 reference

25 December 2017

volume

84

1 reference

25 December 2017

issue

1

1 reference

25 December 2017

page(s)

127-135

1 reference

25 December 2017

The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100491

7 January 2021

Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100491

7 January 2021

Inhibition of K(+)-evoked glutamate release from rat neocortical and hippocampal slices by gabapentin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100491

7 January 2021

Gabapentin inhibits the substance P-facilitated K(+)-evoked release of [(3)H]glutamate from rat caudial trigeminal nucleus slices

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100491

7 January 2021

Progress report on new antiepileptic drugs: a summary of the fourth Eilat conference (EILAT IV)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100491

7 January 2021

A two-part mixture model for longitudinal adverse event severity data

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100491

7 January 2021

Population pharmacodynamic model for ketorolac analgesia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100491

7 January 2021

Quantitative characterization of therapeutic index: application of mixed-effects modeling to evaluate oxybutynin dose-efficacy and dose-side effect relationships

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100491

7 January 2021

Identifiers

DOI

10.1038/SJ.CLPT.6100491

1 reference

25 December 2017

1 reference

25 December 2017